This study analyzes the implementation of marketing innovation and its implications for sales performance at PT Pakar Biomedika Indonesia, an Indonesian company operating in the medical device and diagnostic sector. The study employs a qualitative single-case study approach using an interpretive perspective. Primary data were obtained through an in-depth interview with the Marketing Manager and supported by direct observation and company documentation. The data were analyzed through data condensation, thematic analysis, interpretation, and triangulation to identify patterns related to marketing innovation and sales performance. The findings indicate that the company has implemented marketing innovation across product, price, promotion, and place or distribution. Product innovation involves the development of new products and variants as well as improvements in packaging and design. Pricing innovation includes market- and competitor-based pricing strategies and volume-based flexibility, while promotional innovation combines conventional and digital communication channels. Distribution innovation is implemented through distributor networks, e-catalog and non-e-catalog channels, OEM cooperation, national distribution, and B2B channels. Despite these initiatives, sales target achievement declined from 65.98% in 2023 to 46.13% in 2025. Internal constraints include budget limitations, human resource capacity, competence, time, and product development costs, while external challenges involve competitor pricing, distributor commitment, procurement system changes, regulatory requirements, and the specialized characteristics of medical devices. The study concludes that marketing innovation is strategically important, but its contribution to sales performance depends on the integration of organizational resources, dynamic capabilities, customer education, and effective distribution management.
Copyrights © 2026